Summary
The purpose of this study was to examine sex and race differences in improvement after 6 weeks of phenothiazine or placebo treatment among newly-admitted, acutely-ill schizophrenic patients. The following results were obtained.
-
1.
Although patients on drug treatment improved more than patients receiving placebo in both sexes, the drug-placebo difference was larger for females than for males.
-
a)
On placebo treatment males improved markedly more than female patients.
-
b)
On drug treatment females improved slightly but significantly more than males.
-
2.
Although more improvement was obtained in both white and Negro patients under drug treatment than under placebo, there was a greater drug-placebo difference among the white patients than the Negro patients. However, the results were less consistent than those on sex differences.
-
a)
On placebo treatment Negroes improve more than whites.
-
b)
Under drug treatment no race differences were detected.
-
3.
Race differences under placebo were slightly more evident in ward behavior observed by the nurses than in psychopathology seen by the doctors during the interview.
-
4.
A tentative interpretation of the results is offered in terms of an interaction between factors of genetic predisposition and psychological stress; i.e., improvers on placebo are those whose etiology is more highly loaded on psychological stress factors, and improvers on drug have higher loadings on genetic factors. The interpretation implies greater psychological stress in the etiology of males than females, and of Negroes than whites.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Astrup, C., A. Fossum, and R. Holmboe: Prognosis in the functional psychoses. Springfield, Ill.: Ch. C. Thomas 1962.
Bean, L. L., J. K. Myers, and M. P. Pepper: Social class and schizophrenia: a ten-year follow-up. In: A. B. Shostak and W, Gomberg (Eds.): Blue collar world; studies of the American worker. Englewoods Cliffs, N. J.: Prentice-Hall, Inc. 1964.
Burdock, E. I., G. Hakerem, Anne S. Hardesty, and J. Zubin: Ward behavior rating scale. New York State Psychiatric Institute 1959.
Distler, L. S., P. R. A. May, and A. H. Tuma: Anxiety and ego strength as predictors of response to treatment in schizophrenic patients. J. cons. Psychol. 28, 170–177 (1964).
Farina, A., N. Garmezy, and H. Barry: Relationship of marital status to incidence and prognosis of schizophrenia. J. abnorm. soc. Psychol. 67, 624–630 (1963).
Fuller, R. G.: Expectation of hospital life and outcome for mental patients on first admission. Psychiat. Quart. 4, 295–323 (1930).
Goldberg, S. C., J. O. Cole, and D. J. Clyde: Factor analyses of ratings of schizophrenic behavior. Psychopharmacol. Serv. Center Bull. 2, 23–28 (1963).
Hamilton, J., A. Hordern, F. N. Waldrop, and J. Lofft: A controlled trial on the value of prochlorperazine, trifluoperazine, and intensive group therapy. Brit. J. Psychiat. 109, 510–522 (1963).
Hollingshead, A. B., and F. C. Redlich: Social class and mental illness. New York: John Wiley 1958.
Lehrman, N. F.: A state hospital population five years after admission. Psychiat. Quart. 34, 658–681 (1960).
Lorr, M., C. J. Klett, D. M. McNair, and J. J. Lasky: Inpatient Multidimensional Psychiatric Scale (IMPS) Manual. Palo Alto: Consulting Psychologists Press 1963.
Mischel, W.: Father-absence and delay of gratification. J. abnorm. soc. Psychol. 63, 116–124 (1961).
National Institute of Mental Health — Psychopharmacology Service Center Collaborative Study Group., Phenothiazine treatment in acute schizophrenia. Arch. gen. Psychiat. 10, 246–261 (1964).
Nuttall, R. S.: Some correlations of high need for achievement among urban northern Negroes. J. abnorm. soc. Psychol. 68, 593–600 (1964).
Pollack, E. S., P. H. Person, M. Kramer, and H. Goldstein: Patterns of retention, release, and death of first admissions to state mental hospitals. Publ. Hlth Monogr. 58 (1959).
Rosenthal, D.: Sex distribution and the severity of illness among samples of schizophrenic twins. J. psychiat. Res. 1, 26–36 (1961).
Shepherd, M.: A study of the major psychoses in an English county. London: Chapman and Hall 1957.
Zubin, J., E. I. Burdock, S. Sutton, and F. Cheek: Epidemiological aspects of prognosis in mental illness. In: Epidemiology of mental disorder, American Association for the Advancement of Science, Washington, D.C., 1959.
—, S. Sutton, K. Salzinger, Suzanne Salzinger, E. I. Burdock, and D. Peretz: A biometric approach to prognosis in schizophrenia. In: P. H. Hoch, and J. Zubin (Eds.): Comparative epidemiology of the mental disorders. New York: Grune and Stratton 1961.
Author information
Authors and Affiliations
Additional information
This study was supported by NIMH grants numbered MH 04661,04663, 04667, 04673, 04674, 04675, 04679, 04803, and by NIMH Contract No. SA-43-ph-3064.
Rights and permissions
About this article
Cite this article
Goldberg, S.C., Schooler, N.R., Davidson, E.M. et al. Sex and race differences in response to drug treatment among schizophrenics. Psychopharmacologia 9, 31–47 (1966). https://doi.org/10.1007/BF00427702
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00427702